TY - JOUR
KW - COVID-19
KW - Medication for opioid use disorders
KW - policy
KW - Substance use disorder
KW - Substance use treatment
KW - unmet treatment need
AU - E. D. Nesoff
AU - M. E. Marziali
AU - S. S. Martins
A1 - 
AD - Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA.; Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA.
BT - Addiction (Abingdon, England)
C5 - Healthcare Disparities; Healthcare Policy; HIT & Telehealth; Opioids & Substance Use
CY - England
DO - 10.1111/add.15778
JF - Addiction (Abingdon, England)
LA - eng
M1 - Journal Article
PB - Society for the Study of Addiction
PP - England
PY - 2021
SN - 1360-0443; 0965-2140
T1 - The estimated impact of state-level support for expanded delivery of substance use disorder treatment during the COVID-19 pandemic
T2 - Addiction (Abingdon, England)
TI - The estimated impact of state-level support for expanded delivery of substance use disorder treatment during the COVID-19 pandemic
U1 - Healthcare Disparities; Healthcare Policy; HIT & Telehealth; Opioids & Substance Use
U2 - 34873783
U3 - 10.1111/add.15778
VO - 1360-0443; 0965-2140
Y1 - 2021
Y2 - Dec 7
ER -